Heart Failure 2024: Cutting-edge science and stimulating discussions in heart failure management

Cutting edge science and stimulating discussions in heart failure management are in store at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC).

Haemato AG (von First Berlin Equity Research GmbH) – Biotech Investments

Original-Research: Haemato AG – von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Haemato AG Unternehmen: Haemato AG ISIN: DE000A289VV1

December 14, 2023

FDA approves Pfizer’s RSV vaccine designed to protect newborns by immunizing parent

The Food and Drug Administration on Monday approved a Pfizer vaccine that aims to protect newborns against RSV by vaccinating pregnant people in the latter

August 21, 2023

Aspirin for CRC Risk Reduction May Benefit Unhealthy People Most

Regular aspirin use was associated with a reduced risk of colorectal cancer (CRC) among individuals with less healthy lifestyles, according to results from a prospective

August 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.